Chad vs Viet Nam: Tuberculosis patients living with HIV receiving antiretroviral therapy
Chad
1,543 patients
in 2021
Viet Nam
1,521 patients
in 2021
Chad rank
30th
Viet Nam rank
31st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Chad
- Viet Nam
How they compare
Chad currently reports 1,543 patients against 1,521 patients in Viet Nam, a difference of 22 patients.
The two have swapped places 1 time across 12 shared years of data; in 2009 it was Viet Nam ahead.
Chad ranks 30th and Viet Nam ranks 31st of 183 countries.
Viet Nam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 299 patients | 354 patients | 55 patients | Viet Nam |
| 2010s | 848.22 patients | 2,493 patients | 1,645 patients | Viet Nam |
| 2020s | 1,437 patients | 1,910 patients | 472.5 patients | Viet Nam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Chad or Viet Nam?
- Chad, at 1,543 patients against 1,521 patients in Viet Nam as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Chad and Viet Nam?
- 22 patients, with Chad ahead.
- How many years of comparable data are there for Chad and Viet Nam?
- 12 years are reported by both, from 2009 to 2021.
- How do Chad and Viet Nam rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Chad ranks 30th and Viet Nam ranks 31st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.